DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I.
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
N Engl J Med 2001; 345: 851-860
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.